Budi Starch Sweetener Tbk vs Merck Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 926.79B, 1.2K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Merck Tbk. is more actively traded (21.9K versus 1.2K). Which is the better fit depends on your goals.
| BUDI | MERK | |
|---|---|---|
Market Cap | 926.79B | 1.7T |
Volume | 1.2K | 21.9K |
Lot | 12 | 219 |
Turnover | 247.2K | 83.99M |
Average Price | 206 | 3,834.93 |
Value | 247.2K | 83.99M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →